Registration is required. Registration for the SAMHSA Buprenorphine Clinical Discussion
WebBoard is open to physicians holding waivers from SAMHSA to practice opioid addiction
treatment under the authority of the Drug Addiction Treatment Act of 2000 (DATA). If you
are a physician holding a DATA waiver and would like to register for the SAMHSA
Buprenorphine Clinical Discussion WebBoard, click here for the
registration page. An e-mail will be sent to you to confirm your registration.
You must register with the same e-mail address you provided on the Notification of Intent
(NOI) you submitted to SAMHSA to obtain your DATA waiver. If you would like to register but
did not provide an e-mail address on your original NOI, please contact us by e-mail at
Registrations submitted from individuals other than physicians holding DATA waivers
will be declined.
For information about DATA, opioid addiction treatment with buprenorphine, or the
SAMHSA Buprenorphine Clinical Discussion WebBoard, visit the SAMHSA Buprenorphine
Website at http://www.buprenorphine.samhsa.gov
or e-mail us at firstname.lastname@example.org.